Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-039679
Filing Date
2015-05-06
Accepted
2015-05-06 21:09:39
Documents
1
Period of Report
2015-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7157
  Complete submission text file 0001209191-15-039679.txt   8630
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tibira Therapeutics, Inc. (Issuer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 550 HAMILTON AVE., SUITE 100 PALO ALTO CA 94301
Business Address
Heron Patrick J (Reporting) CIK: 0001365617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35953 | Film No.: 15839102